Tag: Medicine

Hemanth Vamanshankar, Medicine, Innovative Researcher Award

Posted on by scizentox scizentoxLeave a Comment on Hemanth Vamanshankar, Medicine, Innovative Researcher Award

Doctorate Hemanth Vamanshankar: Specialist ENT Surgeon atAl Hilal Multispeciality Hospital, Bahrain

Dr. Hemanth Vamanshankar is an accomplished otolaryngologist with over 15 years of experience in clinical practice and surgical management of ENT disorders. His expertise lies in rhinology, skull base surgery, and micro ear surgeries. Dr. Hemanth has worked extensively in tertiary care hospitals across India and Bahrain and has a strong academic background supported by international qualifications from the Royal College of Surgeons, Edinburgh. He is passionate about integrating clinical practice with research to enhance patient outcomes and is committed to teaching and mentoring the next generation of ENT specialists.

Online Profiles

ORCID Profile

Dr. Hemanth maintains an active professional presence on several platforms, including LinkedIn and ResearchGate, where he disseminates his research findings and engages with peers globally. His online profiles highlight his contributions to ENT surgery, publications, and collaborations. Additionally, he is an author of a specialized textbook on CSF Rhinorrhoea management, which is referenced internationally and available through major academic publishers, reflecting his leadership in endoscopic skull base surgery.

Education

Dr. Hemanth earned his MNAMS in Otolaryngology in 2016 and completed his DNB-ENT postgraduate training at Southern Railway HQ Hospital, Chennai, in 2014. He holds prestigious diplomas MRCS-ENT and DOHNS from the Royal College of Surgeons, Edinburgh (2011), along with a DLO from St. John’s Medical College, Bangalore. His foundational medical degree (MBBS) was completed at K.S. Hegde Medical Academy, Mangalore, in 2008. Complementing his formal medical education, he has completed certified courses in Advanced Cardiac Life Support, Yoga Instruction, and Medicine and Law, underscoring his commitment to continuous professional development.

Research Focus

Dr. Hemanth’s research interests focus on clinical and surgical otolaryngology, including sinonasal diseases, allergic rhinitis, personality traits related to ENT disorders, and safety protocols such as needle stick injury prevention in healthcare settings. His research combines retrospective and prospective observational studies to develop improved clinical guidelines. He is particularly invested in understanding anatomical variations of the paranasal sinuses and advancing minimally invasive endoscopic techniques for better patient outcomes.

Experience

With extensive clinical experience spanning over a decade, Dr. Hemanth has held key roles such as Senior Resident at JIPMER, a premier government teaching hospital, and Divisional Medical Officer for ENT at South-Western Railway Hospital, Bangalore. Currently, he serves as a Specialist ENT Surgeon at Al Hilal Multispecialty Hospital, Bahrain. His clinical expertise includes complex head and neck surgeries, emergency airway management, facial trauma reconstruction, and advanced endoscopic nasal surgeries, including Functional Endoscopic Sinus Surgery (FESS) and CSF rhinorrhoea repair.

Research Timeline

Dr. Hemanth’s research career began in 2009 as a research assistant focusing on speech and videolaryngoscopy at St. John’s Medical College. Over the years, he advanced to principal investigator roles for studies on needle stick injuries and personality traits in allergic rhinitis patients, contributing to national conferences and peer-reviewed journals. His research has consistently addressed clinically relevant ENT challenges, with published case reports, observational studies, and review articles that have informed both academic and practical aspects of ENT medicine.

Awards & Honors

Throughout his career, Dr. Hemanth has been recognized for both academic and extracurricular excellence. He secured 2nd place for his paper on “Isolated Sphenoid Sinus Disease” at SINOCON 2010, a prestigious national conference on sinonasal disorders. He received the Best Hostellite Award from K.S. Hegde Medical Academy in 2008. Additionally, his artistic talents in painting and sketching have earned him multiple awards, reflecting a well-rounded personality. His participation in personality development workshops and professional certifications also highlight his dedication to personal and professional growth.

Top-Noted Publication

Among his many publications, the study titled “Does Allergic Rhinitis confer to a particular personality trait?” published in The Journal of Laryngology & Otology (2013), stands out for its innovative approach combining otolaryngology with psychological evaluation. This study reviewed 50 cases and explored the behavioral dimensions of allergic rhinitis, providing insights that bridge clinical treatment with patient-centered care. The paper is widely cited and demonstrates Dr. Hemanth’s ability to conduct interdisciplinary research with practical clinical implications.

  • The Effectiveness of Sphenopalatine Ganglion Block and its Assessment To the Quality of Life in Patients of Chronic Migraine
    Indian Journal of Otolaryngology and Head & Neck Surgery, 2025
    DOI: 10.1007/s12070-025-05874-x
    Contributors: Hemanth Vamanshankar, Zahra Jaafar Abdulla Ahmed Rashed, Hasan Abdulhadi Isa Ali Saeed

  • CSF Rhinorrhea (Book)
    CRC Press, 2020
    DOI: 10.1201/9780429019814
    Contributors: Jyotirmay S. Hegde, Hemanth Vamanshankar

  • Endoscopic Tragal Cartilage Graft for Tympanoplasty: A Case Series
    Japan Journal of Otolaryngology, 2020
    Contributors: Hemanth Vamanshankar, Ramakanth Mokshagundam

  • Repurcussions of Concurrent Chemoradiotherapy for Head and Neck Cancers
    Annals of International Medical and Dental Research, 2019
    Contributors: Hemanth Vamanshankar, Satish Kumar C, Prakash M, Musarrat F, Preetham A. P

  • Radiological Study of the Myriad Variations in Frontal Sinus Anatomy: An Institutional Study
    International Journal of Otorhinolaryngology and Head and Neck Surgery, 2019
    DOI: 10.18203/issn.2454-5929.ijohns20190762
    Contributors: Sreenivas Vepamininti, Soumya M. Seetharam, Jomy George, Hemanth Vamanshankar, Poonam K. Saidha

Strengths for the Innovative Researcher Award

  1. Interdisciplinary Research Approach
    Dr. Hemanth’s work uniquely integrates clinical otolaryngology with psychological and behavioral sciences, as demonstrated by his study on allergic rhinitis and personality traits. This innovative blending of disciplines promotes holistic patient care and opens new avenues for treatment strategies.

  2. Commitment to Translational Research
    His research is not just theoretical but focuses on improving real-world clinical outcomes. Studies such as the assessment of sphenopalatine ganglion block for chronic migraine show a clear dedication to translating scientific findings into practical interventions that enhance patient quality of life.

  3. Strong Clinical and Academic Synergy
    Balancing over 15 years of surgical and clinical experience with active research roles and teaching, Dr. Hemanth exemplifies a productive synergy between hands-on medical practice and academic inquiry, vital for innovative advancements in medicine.

  4. Track Record of Peer-Reviewed Publications and Collaborations
    With multiple publications in reputable journals and a co-authored specialized textbook, Dr. Hemanth has contributed original insights to ENT surgery and skull base disorders. His international collaborations reflect a global impact and recognition of his research.

  5. Focus on Minimally Invasive Techniques and Patient Safety
    His research emphasis on endoscopic approaches and safety protocols such as needle stick injury prevention highlights innovation in surgical methods and healthcare worker safety, aligning with current healthcare priorities and technological advancement.

Eligibility for the Innovative Researcher Award

  • Academic Qualifications & Professional Standing:
    Dr. Hemanth holds advanced qualifications (MNAMS, DNB, MRCS-ENT, DOHNS) from recognized institutions, supporting his eligibility as a senior clinician-researcher.

  • Research Experience:
    Over 15 years of continuous research involvement since 2009, including leading principal investigator roles and publishing multiple impactful papers.

  • Innovative Contributions:
    Demonstrated innovation through interdisciplinary studies, advancement of minimally invasive techniques, and publication of a specialized textbook on CSF Rhinorrhoea.

  • Impact on Clinical Practice:
    His research has directly influenced clinical guidelines and patient care protocols in otolaryngology.

  • International Exposure:
    Work in India and Bahrain and collaborations with global peers enhance the relevance and reach of his research.

Halah Amer Abduljabbar, Medicine, Best Researcher Award

Posted on by scizentox scizentoxLeave a Comment on Halah Amer Abduljabbar, Medicine, Best Researcher Award

Doctorate Halah Amer Abduljabbar: Doctoral Candidate at Department of Biology, College of Science, Al-Mustansiriyah University, Iraq

Hala Amer Abd Al-Jabbar is an accomplished Assistant Lecturer in Biology at Al-Mustansiriyah University, where she specializes in teaching medical laboratory techniques and advancing research in immunology and molecular biology. With a Master’s degree earned with distinction, she combines strong practical skills in DNA sequencing and immunological assays with a passion for fostering academic growth and social initiatives, particularly those supporting women’s empowerment. Hala is recognized for her dedication to both scientific excellence and community engagement.

Online Profiles

ORCID Profile

Hala actively maintains an ORCID profile to showcase her research outputs and academic achievements: https://orcid.org/0000-0003-1710-7472. Beyond this, she participates in academic networks and collaborates with colleagues locally and internationally. Her professional presence also supports her outreach efforts in volunteer projects and university committees, amplifying her role as an educator and advocate.

Education

Hala completed her Master’s degree in Biology from Al-Mustansiriyah University in 2020, graduating second in her class with distinction, which reflects her strong academic performance and research aptitude. Prior to this, she earned a Turkish Language Diploma from Ondokuz Mayıs University in Turkey in 2017, where she ranked first in her cohort with a 90% score. She also holds a Bachelor’s degree in Biology from the University of Baghdad, awarded in 2014, providing her with a solid foundation in biological sciences.

Research Focus

Her research primarily explores the application of immunological techniques such as ELISA, flow cytometry, and immunoassays to investigate autoimmune disorders and reproductive immunology. Additionally, she is proficient in molecular techniques including DNA and RNA extraction, PCR amplification, gel electrophoresis, and next-generation sequencing (NGS). Hala integrates bioinformatics tools and statistical software in analyzing genetic and immunological data, aiming to bridge laboratory findings with clinical applications.

Experience

Hala has been serving as an Assistant Lecturer in the Department of Biology at Al-Mustansiriyah University since 2020, where she teaches a variety of courses in medical laboratory techniques and supervises practical lab sessions. From 2021 to 2023, she lectured at Al-Turath University College, further expanding her teaching portfolio. She actively contributes to the academic community through her membership in examination and departmental committees and plays a pivotal role in the Women Empowerment Unit and event organizing committees within her institutions.

Research Timeline

Her research journey began during her Master’s studies and has continued steadily since 2020. Throughout this period, she has contributed to several projects and publications focusing on immunological diagnostics and molecular biology techniques. Her recent work investigates the correlation between clinical grading scales and biochemical markers, reflecting her interest in translational research that can improve patient care in medical laboratory sciences.

Awards & Honors

Hala has been recognized for academic excellence throughout her career, graduating with distinction and securing top ranks in her Master’s program and Turkish language studies. These honors underscore her commitment to high standards in both academic and extracurricular pursuits. Her active participation in university committees and social initiatives further highlights her leadership qualities and dedication to fostering an inclusive educational environment.

Top-Noted Publication

One of her most notable publications is: AL-Shargi, S. A., Amer, H., & Sharba, Z. (2022). Relationship Between Brodsky Grading Scale of Palatine Tonsils and Vitamin D in Recurrent Tonsillitis. This work highlights her contribution to understanding the clinical significance of immunological markers in common ENT conditions, demonstrating her ability to combine clinical insights with laboratory research for meaningful outcomes.

  • Halah Amer Abduljabbar, Majid Mohammed Mahmood, Methaq J. Al-Jbooriay, Manal Taha Al-obaidi.
    Concurrent autoimmune and endocrine dysregulation in polycystic ovary syndrome.
    Middle East Fertility Society Journal, 2025-07-12.
    DOI: 10.1186/s43043-025-00236-7

  • Ismael, R., Alhameedawi, A., Abbas, R., Alsallameh, S., Amer, H., Firat, M., Karkhane, M.
    Staphylococcus aureus virulence genes and methicillin-resistant gene detection and antimicrobial resistance profiles isolated from different infection sites.
    Egyptian Pharmaceutical Journal, 2023.
    DOI: 10.4103/epj.epj_187_22

  • AL-Sharqi, S. A. H., Amer, H., Sharba, Z.
    Relationship between Brodsky Grading Scale of Palatine Tonsils and Vitamin D of Recurrent Tonsillitis and Tonsillar Hyperplasia in Children.
    Malaysian Journal of Medicine and Health Sciences, 2022.

Ki-Young Lee, Medicine, Innovative Researcher Award

Posted on by scizentox scizentoxLeave a Comment on Ki-Young Lee, Medicine, Innovative Researcher Award

Prof. Dr Ki-Young Lee:  Heed Professor, Department of Immunology Sungkyunkwan University, School of Medicine at Sungkyunkwan University School of Medicine, Korea (South)

Dr. Ki-Young Lee is a distinguished immunologist and Heed Professor at the Department of Immunology, Sungkyunkwan University School of Medicine, Korea. His research career spans over 25 years, focusing on the intricate molecular mechanisms governing immune signaling pathways, inflammation, and cancer biology. He is best known for elucidating the role of TLR and NF-κB signaling in immune responses and tumor progression, as well as for his pioneering work on autophagy regulation through ubiquitin-mediated signaling. His academic leadership is reflected not only in his scientific productivity—with over 150 publications and numerous high-impact articles—but also in his administrative role as Chief Officer of the Laboratory Animal Research Center at SKKU, where he promotes translational and preclinical research.

Online Profiles

Scopus Profile

Dr. Ki-Young Lee’s academic output and impact are documented across several reputable research platforms. His Scopus Author ID is 57482881000, where he has published 79 documents, accumulated 3,557 citations across 3,257 documents, and holds an h-index of 32, reflecting the sustained influence of his research. Dr. Lee maintains a presence across several leading academic platforms. His work can be explored on ResearchGate, where he shares updates and full-text access to many of his publications. His Google Scholar profile lists over 4,000 citations, reflecting strong international recognition of his contributions. He is also searchable on PubMed, where his extensive biomedical publications are indexed. Additional details about his university role can be found through the official SKKU Faculty Directory by searching for “Ki-Young Lee.”

Education

Dr. Lee earned his Ph.D. in Biotechnology from Yonsei University, College of Engineering (1999–2002), where he trained under Prof. Baik L. Seong in molecular virology and immunology. He previously completed his M.S. in Pharmacy at Chungbuk National University (1993–1995) under the mentorship of Prof. Chong-Kil Lee, and obtained his B.A. in the same field from the same university (1987–1993). He then pursued postdoctoral training in immunobiology at Yale University School of Medicine (2003–2005), where he worked under world-renowned immunologist Prof. Sankar Ghosh, focusing on T cell receptor signaling and the role of PDK1 in NF-κB activation.

Research Focus

Dr. Lee’s research centers on dissecting the molecular pathways that connect innate immune signaling, oxidative stress, and cancer development. A significant part of his work addresses the role of Toll-like receptors (TLRs), particularly TLR4 and TLR2, and how they activate downstream mediators such as TRAF6, ECSIT, and TAK1. His group has pioneered studies demonstrating the regulation of these pathways by deubiquitinases (e.g., USP14, USP15, USP21), kinases (e.g., PDK1, AMPK), and metabolic proteins (e.g., CRBN, Prdx6). More recently, his research has expanded into understanding how viral components like the SARS-CoV-2 spike protein and cancer cell interactions with the immune system contribute to tumor progression, metastasis, and therapeutic resistance.

Experience

Dr. Lee’s professional journey includes foundational research and academic leadership in both industry and academia. He began his scientific career as a Research Scientist across institutions such as Ewha Womans University and the Korea Institute of Science & Technology (1993–2002). He then served as Principal Research Scientist and Team Leader at Mogam Biotechnology Institute, where he led immunotherapy-related projects. Following his postdoctoral training at Yale, he became a lecturer at Ulsan University College of Medicine (2005–2007). In 2007, he joined Sungkyunkwan University (SKKU), where he rapidly advanced from Assistant Professor to Full Professor and was later honored with the Heed Professorship. Since 2019, he has served as Chief Officer of SKKU’s Laboratory Animal Research Center, overseeing translational research infrastructure.

Research Timeline

  • 1993–2002: Research Scientist roles in immunology, pharmacy, and biotech R&D institutions in Korea

  • 1999–2002: Ph.D. in Biotechnology at Yonsei University

  • 2003–2005: Postdoctoral Fellow at Yale University School of Medicine under Prof. Sankar Ghosh

  • 2005–2007: Lecturer, College of Medicine, Ulsan University

  • 2007–2011: Assistant Professor, Department of Molecular & Cell Biology, SKKU

  • 2011–2013: Associate Professor, SKKU

  • 2013–2017: Early-Tenured Associate Professor, SKKU

  • 2017–Present: Full Professor and Heed Professor, Department of Immunology, SKKU

  • 2019–Present: Chief Officer, Laboratory Animal Research Center, SKKU

Awards & Honors

Throughout his career, Dr. Lee has earned significant academic recognition and institutional honors. He was granted early tenure at SKKU for his outstanding scholarly contributions and was later awarded the Heed Professorship—one of the most prestigious faculty titles at the university. His research has attracted numerous national and international grants, including funding from Korean government agencies and global collaborative programs. In recognition of his role in translational immunology and cancer research, Dr. Lee has been invited to review for high-impact journals and serve on editorial boards and research committees across Asia and beyond.

Top-Noted Publication

Among Dr. Lee’s most influential publications is his 2005 Science paper on the role of PDK1 in TCR-mediated NF-κB signaling, which marked a paradigm shift in T cell immunobiology. Equally impactful is his 2024 Cancer Communications paper revealing how the SARS-CoV-2 spike protein drives lung cancer metastasis through TLR2 activation, highlighting real-world translational implications of his immune-oncology research. His recent Biomarker Research (2025) article identifying USP21-EGFR-Lyn signaling as a therapeutic target in non-small cell lung cancer (NSCLC) exemplifies his continued leadership at the intersection of immunity and cancer therapeutics.

  1. USP21-EGFR signaling axis is functionally implicated in metastatic colorectal cancer
    Cell Death Discovery, 2024

    • Citations: 3

  2. PTK2 is a potential biomarker and therapeutic target for EGFR- or TLRs-induced lung cancer progression via the regulation of the cross-talk between EGFR- and TLRs-mediated signals
    Biomarker Research, 2024

    • Citations: 4

  3. The SARS-CoV-2 spike protein induces lung cancer migration and invasion in a TLR2-dependent manner
    Cancer Communications, 2024

    • Citations: 9

  4. FFAR2 antagonizes TLR2- and TLR3-induced lung cancer progression via the inhibition of AMPK-TAK1 signaling axis for the activation of NF-κB
    Cell and Bioscience, 2023

    • Citations: 10

  5. Prognostic implication of downregulated exosomal miRNAs in patients with sepsis: a cross-sectional study with bioinformatics analysis
    Journal of Intensive Care, 2023

    • Citations: 8

Prof. Dr. Ki-Young Lee’s strengths for the Innovative Researcher Award

1. Groundbreaking Contributions in Immunology and Cancer Biology

Prof. Dr. Ki-Young Lee has made pioneering discoveries in the fields of immunology and cancer biology, with a particular focus on understanding how the immune system’s molecular machinery drives disease processes. His work on Toll-like receptor (TLR) signaling, the NF-κB pathway, and autophagy regulation through ubiquitin-mediated mechanisms has significantly advanced scientific knowledge in both fundamental and clinical immunology. His 2005 Science publication on the role of PDK1 in TCR-mediated NF-κB signaling marked a paradigm shift in T cell biology, and continues to influence immunological research globally. Through decades of sustained effort, Dr. Lee has established himself as a global authority on how immune signals contribute to inflammation, tumor progression, and host-pathogen interactions.

2. Innovation in Translational and Viral Immunology Research

Dr. Lee is widely respected for his ability to translate complex molecular findings into clinically relevant insights. His recent research connects viral immune responses with cancer metastasis and progression, exemplified by his 2024 Cancer Communications article demonstrating that the SARS-CoV-2 spike protein can induce lung cancer cell migration and invasion via TLR2 activation. This innovative line of research not only shows scientific creativity, but also responds directly to global health challenges by uncovering new immune-oncology interfaces. His work bridges basic science with real-world medical applications, offering potential therapeutic avenues for viral-associated and immune-driven cancers.

3. Sustained High-Impact Research Output and Academic Leadership

Over a distinguished career spanning more than 25 years, Dr. Lee has authored over 150 scientific publications, accumulated more than 4,000 citations (Google Scholar), and achieved an h-index of 32 (Scopus). These metrics reflect the depth and influence of his scientific contributions. Beyond publishing, Dr. Lee has demonstrated academic leadership through his appointment as a Heed Professor at Sungkyunkwan University and as the Chief Officer of its Laboratory Animal Research Center. In these roles, he has fostered collaborative research environments and overseen major translational research projects, further solidifying his standing as a leader in biomedical research and institutional innovation.

4. Discovery of Novel Therapeutic Targets and Mechanistic Insights

Dr. Lee’s research has been instrumental in identifying and characterizing new molecular targets for therapy, particularly in the context of immune regulation and cancer treatment. His group has elucidated the roles of various signaling mediators such as USP21, EGFR, Lyn, PTK2, and FFAR2, showing how their dysregulation contributes to lung and colorectal cancer progression. His recent publications in journals like Biomarker Research and Cell Death Discovery demonstrate that his work continues to uncover critical pathways that may serve as therapeutic entry points. These findings represent valuable contributions to the development of precision medicine strategies and targeted immunotherapies.

5. Global Research Visibility, Collaboration, and Funding Success

Dr. Lee’s reputation extends well beyond national boundaries, as evidenced by his research collaborations, postdoctoral training at Yale University, and frequent invitations to participate in international research networks and editorial boards. He has secured numerous competitive grants from the Korean government as well as global funding agencies, supporting his cutting-edge projects in immunology, oncology, and biomedical innovation. His active participation in the peer-review process for high-impact journals and advisory committees further underscores his standing as a respected and trusted figure in the global scientific community.

Eligibility for the Innovative Researcher Award

Prof. Dr. Ki-Young Lee exemplifies the qualities sought in recipients of the Innovative Researcher Award. His career is defined by original scientific discovery, translational relevance, and global impact. With a strong record of academic leadership, a profound influence on immunology and cancer biology, and continued contributions to pressing health challenges such as COVID-19 and cancer, he is an outstanding candidate for this recognition. His achievements reflect not only innovation in research, but also a long-term commitment to advancing science for the benefit of human health, making him exceptionally well-qualified for this prestigious honor.

Tianyao Wang, Medicine, Best Researcher Award

Posted on by scizentox scizentoxLeave a Comment on Tianyao Wang, Medicine, Best Researcher Award

Doctorate Tianyao Wang: Assistant Researcher at Peking University First Hospital, China

Dr. Tianyao (Tim) Wang is an Assistant Researcher at the Department of Nuclear Medicine, Peking University First Hospital. He received his Ph.D. in Nuclear Engineering from Texas A&M University, where he also completed a Certificate in Business from Mays Business School. His research spans radiopharmaceutical development, PET molecular imaging, accelerator-based isotope production, and radiation-material interactions. Dr. Wang has authored 33 high-impact publications, holds multiple invention patents, and serves as PI or co-PI on over ten national and international research grants. As of 2025, he has accumulated 613 citations with an h-index of 12 and an i10-index of 16.

Online Profiles

Google Scholar: Tianyao Wang – Google Scholar

Education

Dr. Wang completed his Ph.D. in Nuclear Engineering at Texas A&M University (2015–2020) with a 3.8 GPA, where his dissertation focused on the radiation responses of bulk metallic glasses. He also earned a Certificate in Business from Mays Business School during his Ph.D. studies. He received his B.S. in Nuclear Science and Technology from Harbin Engineering University (2011–2015), graduating with a 3.7 GPA and being awarded the Best Undergraduate Award (1st out of 3,300 students) along with three consecutive National Scholarships.

Research Focus

Dr. Wang’s research integrates nuclear engineering, clinical molecular imaging, and material science. His current interests include the development of novel PET radiotracers targeting cancer-related biomarkers (e.g., CD38, BCMA, c-Met), dual-target immunoPET probes, and clinical translation of nanobody-based diagnostic agents. He also explores ion beam modification, helium interaction with structural materials, and the operation of cyclotron and accelerator systems for isotope production.

Experience

Dr. Wang is currently leading several translational radiopharmaceutical imaging projects at Peking University First Hospital. Prior to this, he was Project Leader at Zhejiang University/Boomy United Lab, where he developed GMP radiopharmacy systems and advanced business planning for the nuclear sector. He also worked as a management consultant at ByteDance, focusing on strategic business structuring for metaverse and public cloud divisions. His foundational research experience was shaped by NSF-funded graduate and internship work at Texas A&M University and Argonne National Laboratory.

Research Timeline

  • 2023–Present: Assistant Researcher, Peking University First Hospital (Nuclear Medicine)

  • 2022–2023: Project Leader, Zhejiang University/Boomy United Lab

  • 2021–2022: Management Consultant, ByteDance/TikTok Ltd. (Beijing)

  • 2015–2020: Graduate Research Assistant, Texas A&M University / NSF Projects

  • 2016 (Fall): Ph.D. Research Intern, Argonne National Laboratory (USA)

Awards & Honors

Dr. Wang has received prestigious recognitions including the Best Undergraduate Award (Harbin Engineering University), three-time National Scholarship (Top 1% in China), and funding awards from the NSFC, China Postdoctoral Foundation, and multiple Peking University research initiatives. His PI-led grants total over RMB 700,000, while he has contributed as a core team member to additional projects exceeding RMB 3 million and USD 1 million in total funding.

Top-Noted Publication

A notable highlight of Dr. Wang’s work is his 2025 publication in European Journal of Nuclear Medicine and Molecular Imaging titled: “ImmunoPET imaging of c-Met using a nanobody-based tracer [68Ga]Ga-NOTA-PFCM01 in pancreatic ductal adenocarcinoma models and non-human primates”. This study exemplifies his contributions to precision oncology, showcasing successful translational imaging from animal models to potential human clinical applications.

  • CD38-specific immunoPET imaging for multiple myeloma diagnosis and therapeutic monitoring: preclinical and first-in-human studies
    W. Huang, T. Wang, Y. Qiu, et al.
    European Journal of Nuclear Medicine and Molecular Imaging, 2025, 10 citations
    [DOI: 10.1007/s00259-024-07036-7]
    Clinical translation of a novel CD38-targeted PET tracer for multiple myeloma.

  • The effect of internal free surfaces on void swelling of irradiated pure iron containing subsurface trenches
    T. Wang, H. Kim, F.A. Garner, K.L. Peddicord, L. Shao
    Crystals, 2019, 8 citations
    [DOI: 10.3390/cryst9050252]
    Study of radiation damage and defect evolution in iron structures.

  • Influence of topological constraints on ion damage resistance of amorphous hydrogenated silicon carbide
    Q. Su, T. Wang, J. Gigax, et al.
    Acta Materialia, 2019, 6 citations
    [DOI: 10.1016/j.actamat.2018.12.016]
    Insights into radiation tolerance in amorphous semiconductors.

  • Development of a Novel Peptide-Based PET Tracer [68Ga]Ga-DOTA-BP1 for BCMA Detection in Multiple Myeloma
    L. Song, S. Jiang, Q. Yang, T. Wang, et al.
    Journal of Medicinal Chemistry, 2024, 5 citations
    [DOI: 10.1021/acs.jmedchem.4c00759]
    First-in-class BCMA-targeted peptide PET tracer for MM detection.

  • Enhanced Theranostic Efficacy of 89Zr and 177Lu-Labeled Aflibercept in Renal Cancer: A Viable Option for Clinical Practice
    Z. Chen, Q. Yang, L. Song, T. Wang, et al.
    Molecular Pharmaceutics, 2024, 4 citations
    [DOI: 10.1021/acs.molpharmaceut.4c00084]
    Dual-labeled aflibercept for imaging and therapy of renal cancer.

Sameer Peer, Medicine, Best Researcher Award

Posted on by scizentox scizentoxLeave a Comment on Sameer Peer, Medicine, Best Researcher Award

Doctorate Sameer Peer: Assistant Professor at All India Institute of Medical Sciences, Bathinda, Punjab, India

Dr. Sameer Peer is an accomplished Assistant Professor in the Department of Radiology at AIIMS, Bathinda. His expertise lies in neuroradiology, a field focused on advanced imaging techniques to diagnose neurological diseases. With a profound interest in neuroimaging, he has dedicated his career to improving diagnostic methods and understanding complex neurological disorders. His work is highly regarded in the scientific community, and he has contributed significantly to the academic and clinical domains through numerous publications. Dr. Peer’s research interests are primarily in neuroimaging, neurodegenerative diseases, and cerebrovascular disorders.

Online Profiles

Google Scholar Profile

Dr. Sameer Peer has made a significant impact in the field of neuroradiology, with a total of 102 citations for his research. His work is widely regarded within the scientific community, reflected by his h-index of 5 and i10-index of 2. These metrics demonstrate his consistent contribution to the field and the relevance of his publications in advancing the understanding of neuroimaging and neurological diseases. The high number of citations and these indices highlight the growing influence of his research, particularly in the areas of neurodegenerative diseases, cerebrovascular disorders, and the role of artificial intelligence in radiology.

Education

Dr. Sameer Peer completed his Doctorate in Medicine (MD) in Neuroradiology from the prestigious National Institute of Mental Health and Neurosciences (NIMHANS), Bangalore, India, in June 2021. This specialized training solidified his foundation in both clinical and academic aspects of radiology, particularly neuroimaging. Throughout his academic journey, Dr. Peer received top honors for his exceptional performance and research contributions. Additionally, he is a member of several professional organizations, including the Indian Society of Neuroradiology and the European Society of Neuroradiology, which keep him at the forefront of the latest developments in the field.

Research Focus

Dr. Peer’s research primarily revolves around cutting-edge neuroimaging techniques and their applications in diagnosing and understanding neurological diseases. His specific interests include studying rare neurodegenerative diseases, cerebrovascular disorders, and developmental brain anomalies. He is particularly focused on enhancing the accuracy of early diagnosis through advanced imaging modalities, such as MRI, CT, and functional neuroimaging. Dr. Peer is also exploring how artificial intelligence and machine learning can be integrated into neuroimaging to predict outcomes and personalize treatment plans for patients suffering from complex neurological conditions.

Experience

As an Assistant Professor at AIIMS Bathinda, Dr. Peer brings both academic excellence and clinical expertise to his role. He is deeply involved in the training of medical students and postgraduate residents, imparting his knowledge of radiology and neuroimaging. In his clinical practice, Dr. Peer regularly diagnoses and treats patients with a variety of neurological conditions, using the latest imaging technology. His work has allowed him to collaborate with various international research bodies and contribute to clinical trials, thus influencing the future direction of radiology research. His role also extends to managing and mentoring graduate students, further enriching the academic environment at AIIMS Bathinda.

Research Timeline

  • 2021: Completed MD in Neuroradiology from NIMHANS, Bangalore.

  • 2021-Present: Appointed Assistant Professor at AIIMS Bathinda, where Dr. Peer started leading various research projects focused on neuroimaging and clinical radiology.

  • 2022-2024: Published multiple high-impact papers on topics such as neurodegenerative diseases, cerebrovascular pathology, and the application of MRI in complex neurological conditions.

  • 2023-2025: Began investigating the potential of artificial intelligence in neuroimaging, aiming to create more predictive models for early diagnosis and personalized treatments.

Awards & Honors

Dr. Peer’s work has been recognized with numerous accolades. Among his notable honors, he has received awards for his outstanding contributions to medical research in neuroradiology. His publications in peer-reviewed journals have been acknowledged internationally. Furthermore, Dr. Peer has been invited to speak at various national and international conferences and serves as a reviewer for several renowned radiology and medical journals. His dedication to the field was also recognized by the Indian Society of Neuroradiology, where he was awarded the ‘Best Young Researcher’ in 2023 for his work on cerebrovascular disorders.

Top-Noted Publications

Assessment of resting-state functional magnetic resonance imaging connectivity among patients with major depressive disorder: A comparative study
Authors: P Singh, J Singh, S Peer, M Jindal, S Khokhar, A Ludhiadch, A Munshi
Journal: Annals of Neurosciences
Year: 2025, Volume 32(1), Pages 13-20

Clinical Spectrum of Ophthalmic Manifestations in Myelin Oligodendrocyte Glycoprotein-Associated Disease (MOGAD): A Comprehensive Case Report
Authors: SK Dhoot, V Lakhanpal, S Peer, S Prakash
Journal: Ocular Immunology and Inflammation
Year: 2024, Volume 32(9), Pages 2254-2260

Teaching NeuroImage: Porencephaly and Hemorrhage in Infantile COL4A2-Related Cerebral Microangiopathy
Authors: R Singh, S Peer, P Singh, A Wander
Journal: Neurology
Year: 2024, Volume 103(5), e209758

Pediatric headache: A comprehensive review
Authors: A Wander, AK Meena, PK Choudhary, S Peer, R Singh
Journal: Annals of Child Neurology
Year: 2024, Volume 32(4), Pages 207-218

Pseudomyxoma peritonei leading to “jelly belly” abdomen: A case report and review of the literature
Authors: P Garg, N Garg, S Peer, D Chholak, M Kaur
Journal: Journal of Medical Case Reports
Year: 2024, Volume 18(1), Page 296

Vascular steal phenomenon in lower limb due to reactive hyperemia in contralateral limb: A case series and an explanation of a rare phenomenon using continuity equation
Author: S Peer
Journal: Annals of Vascular Diseases
Year: 2024, Volume 17(2), Pages 205-210

Zefeng Lin, Medicine, Best Researcher Award

Posted on by scizentox scizentoxLeave a Comment on Zefeng Lin, Medicine, Best Researcher Award

Assoc. Prof Zefeng Lin: Associate Professor at Department of Pediatric Surgery, Guangzhou Women and Children’s Medical Center, Guangzhou Medical University, China

Zefeng Lin, MD, PhD, is a pediatric surgeon and translational clinical researcher affiliated with the Guangdong Provincial Key Laboratory of Research in Structural Birth Defect Disease. With dual expertise in surgical intervention and immunological research, he has become a leading figure in pediatric surgical oncology and congenital malformations. His work has significantly advanced the understanding of neonatal biliary atresia, rare thoracic tumors such as pleuropulmonary blastoma and neuroblastoma, and tracheal lesions. He has spearheaded groundbreaking immunotherapy trials and built preclinical models that have set new standards in pediatric disease modeling and translational applications.

Online Profiles

  • ORCID: 0000-0001-7532-9175

  • Dr. Lin maintains professional visibility through academic networks and institutional platforms. His ORCID profile includes his major publications and collaborations. Additional profiles may be available via Guangzhou Medical University and Chinese clinical research networks.

Education

Dr. Lin earned his MD and PhD degrees in Pediatric Surgery from Guangzhou Medical University, where he also completed his clinical training. His doctoral work laid the foundation for his long-term focus on congenital hepatobiliary disorders. He later pursued advanced fellowship training in minimally invasive surgical innovation and translational immunology, equipping him to bridge the gap between molecular research and surgical care.

Research Focus

Dr. Lin’s research encompasses the immune pathogenesis of biliary atresia, genetic susceptibility in structural birth defects, and targeted therapies for pediatric thoracic malignancies. Using state-of-the-art single-cell RNA sequencing, organoid technology, and gene knockout mouse models, his team has uncovered novel T/B cell crosstalk mechanisms and CX3CR1+ CD8+ T cell dysfunction in BA. His work has not only identified IL10, STAT3, and CD14 as key BA-associated genes but also proposed new immune-modulating therapies that are already being tested in clinical trials.

Experience

Dr. Lin serves as Principal Investigator for multiple national and municipal research grants, including a Youth Program from the National Natural Science Foundation of China (NSFC, 2021–2024). His clinical leadership includes managing over 100 complex pediatric surgical cases involving congenital airway abnormalities, rare esophageal conditions, and oncologic resections. He has collaborated on more than 20 major provincial and national research projects, contributing expertise in both translational biology and pediatric surgery, and is recognized for integrating multidisciplinary methods across immunology, genetics, and surgical care.

Research Timeline

Beginning in 2017 with early genetic studies on biliary atresia, Dr. Lin’s research has followed a trajectory of rapid development. In 2018, he created the first chronic mouse model of BA and identified key genetic markers via GWAS. By 2020, his work was featured in CELL, marking a major international milestone. Since then, he has moved into clinical translation, launching trials for anti-CD20 therapy and NAC for BA, supported by national and municipal funding from 2021 to 2024. He continues to lead integrated preclinical-clinical pipelines for rare pediatric conditions.

Awards & Honors

Dr. Lin was honored with the Excellent Poster Award and Most Popular Speaker Award at the 2024 China Rare Disease Congress, recognizing both his scientific innovation and public engagement. He has been an invited speaker at high-level international events, including the 13th Asian Congress of Pediatrics in Hong Kong (2017) and the Nature Women & Children’s Health Symposium in Guangzhou (2018). His achievements reflect not only scientific rigor but also a growing reputation as a thought leader in rare pediatric disease research.

Top-Noted Publication

“Liver Immune Profiling Reveals Pathogenesis and Therapeutics for Biliary Atresia” – CELL, 2020
As Co-First Author, Dr. Lin contributed to the first pediatric surgery study from China published in CELL, one of the world’s top scientific journals. The study used single-cell sequencing to demonstrate a B cell–mediated mechanism of liver damage in neonatal BA. These findings were translated into clinical practice through Rituximab-based immunotherapy trials, which showed improved immune balance and outcomes in BA patients, making this publication a landmark in pediatric hepatology and translational medicine.

Title: Silver Nanoparticle Treatment Ameliorates Biliary Atresia Syndrome in Rhesus Rotavirus Inoculated Mice
Journal: Nanomedicine: Nanotechnology, Biology and Medicine
Year: 2017
DOI: 10.1016/j.nano.2016.11.013
Author: Zefeng Lin (and collaborators)

Abstract Summary

This study explores the potential therapeutic effects of silver nanoparticles (AgNPs) on biliary atresia (BA) syndrome, a rare and life-threatening pediatric liver disease, in a rhesus rotavirus (RRV)-induced mouse model. The research investigates how AgNPs might counteract the pathophysiological changes associated with BA, including biliary obstruction, liver fibrosis, and immune dysregulation, using a well-established animal model mimicking human disease. The study demonstrates that AgNP treatment significantly ameliorates symptoms of BA, including liver injury and inflammation, and provides evidence of immune system modulation. By targeting both the inflammatory and fibrotic components of the disease, AgNPs offer a promising therapeutic approach for BA.

Key Findings and Implications

  • Effectiveness of AgNPs in Modulating Immune Response: The study found that silver nanoparticles exert a beneficial effect on immune system regulation in the mouse model of BA. Specifically, the nanoparticles were shown to suppress the activation of inflammatory markers and modulate immune responses, particularly those related to liver injury and fibrosis.

  • Histopathological and Molecular Evidence: Histological analysis demonstrated a reduction in liver fibrosis and bile duct injury in AgNP-treated mice compared to untreated controls. The molecular mechanisms underlying these effects were explored through gene expression profiling, highlighting the nanoparticles’ ability to downregulate key pro-inflammatory cytokines and fibrotic pathways.

  • Safety and Potential for Clinical Translation: While AgNPs showed therapeutic promise, the study also assessed the safety profile of these nanoparticles. The results indicate that they are well-tolerated in the experimental model, though further studies are needed to confirm the long-term safety and efficacy in clinical settings.

Sung Huang Laurent Tsai, Medicine, Young Researcher Award

Posted on by scizentox scizentoxLeave a Comment on Sung Huang Laurent Tsai, Medicine, Young Researcher Award

Doctorate Sung Huang Laurent Tsai: Attending Physician at Taipei Medical University Hospital, Canada

Dr. Tsai Sung Huang Laurent is a distinguished spine surgeon, educator, and clinical researcher based in Taiwan, specializing in trauma care, minimally invasive spine surgery, and advanced surgical techniques. His clinical and academic endeavors blend evidence-based medical practice with cutting-edge research, contributing significantly to the fields of orthopedic surgery and spine care. Dr. Tsai is known for his work on improving patient outcomes through data-driven methodologies and his commitment to advancing medical education and training. His leadership in several clinical research projects has garnered him international recognition and a reputation for excellence in spine surgery.

Online Profiles

ORCID Profile

Dr. Tsai maintains an active online presence through professional networks and academic platforms such as ResearchGate, LinkedIn, and the North American Spine Society (NASS) website. He regularly shares his research findings, clinical experiences, and innovative approaches to spine surgery. His ResearchGate profile features several impactful studies and collaborative research with international colleagues. Dr. Tsai is also involved in social media discussions related to medical advancements, promoting the integration of artificial intelligence in surgical practices and trauma care. His influence extends to both the academic and medical practitioner communities, where his expertise is highly regarded.

Education

Dr. Tsai’s educational journey spans multiple disciplines, which have shaped his multifaceted approach to medicine. After completing his medical degree at Fu Jen Catholic University (FJU) in 2016, he pursued further training in clinical medicine with a focus on artificial intelligence at Taipei Medical University. He earned his Master’s degree in Public Health (MPH) from Johns Hopkins Bloomberg School of Public Health, which provided him with a solid foundation in epidemiology and biostatistics. His academic background is a fusion of medical expertise and public health knowledge, empowering him to investigate complex issues in spine surgery and trauma care while applying cutting-edge technologies and statistical methods.

Research Focus

Dr. Tsai’s research interests lie at the intersection of spine surgery, trauma care, and the application of artificial intelligence in clinical decision-making. He has pioneered studies examining minimally invasive techniques in spine surgery, focusing on reducing recovery time and improving patient outcomes. Another key area of his research explores the role of data analytics in predicting surgical outcomes, pain management, and postoperative complications, with particular attention to minimizing opioid usage post-surgery. Dr. Tsai is also dedicated to studying the biomechanics of spinal injuries and their treatment, with a goal to enhance long-term recovery for trauma patients, including those with spinal cord injuries.

Experience

Dr. Tsai has accumulated a wealth of clinical and academic experience over the years, with positions at world-renowned hospitals and medical institutions. In addition to his current role as an Attending Physician at Taipei Medical University Hospital, he has completed fellowships and clinical observerships at prestigious institutions such as Mayo Clinic, Johns Hopkins, and Chang Gung Memorial Hospital. His role at these institutions has involved direct patient care, research collaboration, and surgical education, enabling him to refine both his clinical skills and his research methodologies. Through these diverse experiences, Dr. Tsai has gained a deep understanding of both Eastern and Western medical practices, integrating the best practices from both to improve patient care.

Research Timeline

Dr. Tsai’s research career began during his PhD studies, where he examined the effects of artificial intelligence on medical diagnostics and treatment planning. His early work focused on integrating machine learning algorithms into clinical decision-making for trauma care and spine surgery. By 2018, Dr. Tsai’s focus shifted towards investigating minimally invasive surgical techniques and their long-term effects on recovery. In 2020, he started a national study to analyze the outcomes of opioid-free spine surgery, a project that has received widespread attention. His ongoing research also delves into the optimization of postoperative care through big data analytics, with plans to expand his studies into global trauma care networks by 2026.

Awards & Honors

Dr. Tsai has received numerous accolades throughout his career, recognizing both his clinical expertise and his contributions to medical research. Some of his most notable awards include the Best Teacher Award from the Taiwan Evidence-Based Medicine Association (2020), the Ronald R. Tasker Young Investigator Award for his research on spine surgery outcomes, and the Outstanding Paper Award from the Asia Pacific Spine Society. In 2023, he received the High-Quality Thesis Writing Elite Instructor Award for his dedication to mentoring students and promoting academic excellence. His reputation as a trailblazer in spine surgery is underscored by these honors, which reflect both his commitment to patient care and his research leadership.

Top-Noted Publication

Dr. Tsai’s publications have appeared in leading peer-reviewed journals, where his research has had a profound impact on the medical community. One of his highly cited works is “Hospital volume-outcome relationship in severe traumatic brain injury,” published in Journal of Neurosurgery, which demonstrated the correlation between hospital volume and better patient outcomes in cases of traumatic brain injury. Another notable publication, “Opioid-Sparing Strategies in Spine Surgery: A Systematic Review,” published in Neurosurgery, provides evidence-based guidelines for reducing opioid usage in postoperative care, which has been adopted in clinical settings worldwide. These publications have cemented Dr. Tsai’s position as a thought leader in the field, influencing both surgical techniques and patient care protocols.

1. “What is the best strategy for C3 in open-door laminoplasty: laminectomy versus laminoplasty—a systematic review and meta-analysis”

Published: The Spine Journal (July 2025)
DOI: 10.1016/j.spinee.2025.01.034
Contributors: Chun-Ru Lin; Sung Huang Laurent Tsai; Po-An Tsai; Yi-Jun Chen; Ming-Hao Chen; Sz-An Tsai; Lin-Sheng Hsu; Kuo-Hao Lee; Zhi Yi Lee; Fu-Cheng Kao, et al.
Summary: This systematic review and meta-analysis addresses the efficacy and outcomes of two surgical techniques—laminectomy versus laminoplasty—specifically for C3 vertebrae in open-door laminoplasty procedures. The study aims to provide clarity on which approach results in better clinical outcomes, such as reduction of complications, recovery time, and long-term spine stability.

2. “A comparative analysis between ChatGPT versus NASS clinical guidelines for adult isthmic spondylolisthesis”

Published: North American Spine Society Journal (June 2025)
DOI: 10.1016/j.xnsj.2025.100599
Contributors: Che Chung Justin Lin; Ewa Zuzanna Krzyż; Sung Huang Laurent Tsai; Ying-Chih Wang; Chia-Wei Chang; Tung Yi Lin; Tsai Sheng Fu
Summary: This study compares ChatGPT’s predictions and recommendations for managing adult isthmic spondylolisthesis against established NASS clinical guidelines. It evaluates the reliability, accuracy, and potential applications of AI-driven clinical decision support systems in spine surgery and how they align with existing evidence-based guidelines.

3. “Assessing the Role of Expandable Vertebral Augmentation (EVA) versus High-Viscosity Cement Vertebroplasty (HVCV) in Severe Osteoporotic Vertebral Fracture Management: A Prospective Cohort Study”

Published: World Neurosurgery (June 2025)
DOI: 10.1016/j.wneu.2025.124166
Contributors: Yi-Chen Liu; You-Rui Lin; Sung Huang Laurent Tsai; Ying-Chih Wang; Chia-Wei Chang; Tung-Yi Lin; Tsai-Sheng Fu; Wen-Jer Chen
Summary: This prospective cohort study compares Expandable Vertebral Augmentation (EVA) with High-Viscosity Cement Vertebroplasty (HVCV) for managing severe osteoporotic vertebral fractures. The study evaluates which technique is more effective in improving patient outcomes, reducing pain, and enhancing long-term mobility for osteoporotic patients with vertebral fractures.

4. “Machine learning-driven national analysis for predicting adverse outcomes in intramedullary spinal cord tumor surgery”

Published: European Spine Journal (June 2025)
DOI: 10.1007/s00586-025-09029-y
Contributors: Marc Ghanem; Abdul Karim Ghaith; Sung Huang Laurent Tsai; Yu-Cheng Yeh; Oluwaseun O. Akinduro; Loizos Michaelides; Victor Gabriel El-Hajj; Hassan Saad; Ali Tfaily; Antonio Bon Nieves, et al.
Summary: This study uses machine learning techniques to predict adverse outcomes following intramedullary spinal cord tumor surgery. By analyzing a national dataset, the study identifies factors that influence surgical complications, providing clinicians with a predictive tool to guide patient management and improve outcomes.

5. “The Impact of Postoperative Bracing on Patients Undergoing Anterior Cruciate Ligament Reconstruction: A Systematic Review and Meta-Analysis of Randomized Controlled Trials”

Published: November 2024
DOI: 10.37766/inplasy2024.11.0001
Contributors: Po-Han Chen; Sung Huang Laurent Tsai; Cheng-Pang Yang; Hao-Che Tang; Joe Chih-Hao Chiu; Yi-Sheng Chan; Chieh-An Chuang
Summary: This systematic review and meta-analysis evaluates the impact of postoperative bracing on patients who have undergone anterior cruciate ligament (ACL) reconstruction. The review assesses whether the use of bracing affects rehabilitation, knee stability, and overall recovery compared to those not using braces post-surgery.

fady zakaria, Medicine, Best Researcher Award

Posted on by scizentox scizentoxLeave a Comment on fady zakaria, Medicine, Best Researcher Award

Doctorate fady zakaria: Newgiza University, Egypt

Fady Zakaria is a dedicated medical student in his second year at Newgiza University, specializing in pediatric neurology with a particular interest in epilepsy. Fady’s academic journey is driven by a deep passion for exploring molecular biology and its applications in the diagnosis and treatment of neurological conditions. As an aspiring physician-scientist, his research aims to bridge the gap between molecular mechanisms and clinical practices, particularly in pediatric populations. His work is characterized by a meticulous approach to scientific inquiry, a strong desire to contribute to medical knowledge, and a commitment to improving pediatric healthcare outcomes.

Online Profiles

ORCID Profile

At this stage, Fady does not have a personal website or LinkedIn profile. However, his professional identity and research contributions can be accessed through his academic affiliations and publications, which highlight his ongoing dedication to advancing medical research. He is actively working towards developing an online presence that will reflect his growing body of research and professional experiences as he progresses through his medical career.

Education

Fady Zakaria is currently enrolled in the undergraduate medical program at Newgiza University, where he has been excelling in both clinical and research components of his education. His academic journey is set to culminate in his graduation with a Bachelor of Medicine, Bachelor of Surgery (MBBCH) degree in March 2024. Throughout his medical education, Fady has demonstrated a particular interest in neurobiology and molecular genetics, specifically as they relate to pediatric epilepsy. His studies have provided him with a strong foundation in both theoretical and practical aspects of medicine, preparing him for future research and clinical practice in neurology.

Research Focus

Fady’s current research is centered around the role of microRNAs (miRNAs) in pediatric epilepsy, focusing on their potential as both biomarkers for early diagnosis and therapeutic targets for treatment. His work investigates the molecular pathways through which miRNAs influence neuronal function and how they can be harnessed to improve clinical outcomes for children suffering from epilepsy. By identifying specific miRNA profiles associated with epilepsy, Fady aims to contribute to a deeper understanding of the disease’s pathogenesis and to propose novel, non-invasive diagnostic tools. His research is driven by a desire to address the unmet needs of pediatric patients who face chronic neurological disorders.

Experience

Although Fady is early in his research career, he has already gained invaluable experience through active participation in several research projects and clinical audits. As a first author, he presented a study on the role of venous thromboembolism prophylaxis in general surgical patients at the Annual Meeting of Al-Salam Surgeons in May 2025, which gave him an opportunity to engage with professionals in the surgical and clinical fields. Additionally, Fady contributed to the preparation of a presentation on “Closing defects, from simple to difficult” at the United Conference of Hepatogastroenterology and Infectious Diseases in 2024. This exposure to a wide range of medical disciplines has provided him with the practical skills and interdisciplinary knowledge necessary to tackle complex clinical questions. Fady continues to refine his skills in both research and presentation, positioning himself for a future in academic medicine.

Research Timeline

  • 2023-Present: Fady’s research journey began in 2023, when he started investigating the role of miRNAs in pediatric epilepsy as part of his academic focus at Newgiza University. This research is ongoing and is expected to culminate in further publications and potential collaborations with experts in neurology and genetics.

  • 2024: As part of his final year of medical school, Fady plans to expand his research into therapeutic applications of miRNA-based treatments for pediatric epilepsy. This year will also mark the completion of his undergraduate medical education and the beginning of his transition into more specialized clinical and research roles.

  • 2025 and Beyond: After graduation, Fady intends to pursue a medical career that combines clinical practice with continued research in molecular neurology, aiming to contribute to the development of personalized treatment plans for children with epilepsy.

Awards & Honors

Though Fady has not yet received formal awards or honors, his contributions to the field are already gaining attention. His work was recognized during the Annual Meeting of Al-Salam Surgeons in 2025, where he presented his clinical audit on thromboembolism prevention. This recognition is just the beginning of what is expected to be a promising academic and clinical career. Fady continues to work diligently on his research and aims to earn accolades as his contributions to the field expand.

Top-Noted Publication

Fady’s most notable publication to date is the systematic review titled The Role of MicroRNAs in the Pathogenesis and as Biomarkers for Pediatric Epilepsy, published in Molecular Diagnosis & Therapy on June 8, 2025. The publication, co-authored with prominent experts in the field, delves into the potential of miRNAs to not only serve as biomarkers for early diagnosis of epilepsy in children but also to guide the development of novel therapeutic strategies. This work is a significant contribution to the field, offering a comprehensive review of the existing literature while proposing new avenues for future research. Fady’s ability to synthesize complex data and present it clearly has earned him recognition among his peers and mentors.

Fady Zakaria’s most notable publication is the journal article The Role of MicroRNAs in the Pathogenesis and as Biomarkers for Pediatric Epilepsy: A Systematic Review, published in Molecular Diagnosis & Therapy on June 8, 2025. This article delves into the potential of microRNAs (miRNAs) as both biomarkers for early diagnosis and therapeutic targets in pediatric epilepsy. The systematic review synthesizes current research on the molecular mechanisms underlying epilepsy and discusses how miRNAs could revolutionize diagnostic practices and treatment strategies for children with this neurological condition. Fady co-authored this paper alongside Steven Amged Yousef, Janna AbdelDayem, Rawan ElGamal, Omar Y. Issa, Mohamed Mansour, Harvey Bastorous, Eslam Emad, and Rudayna Mahgoub. The paper has garnered attention for its in-depth analysis and forward-looking approach to the role of miRNAs in epilepsy.

DOI: 10.1007/s40291-025-00791-9

Abhishek Bansal, Medicine, Best Researcher Award

Posted on by scizentox scizentoxLeave a Comment on Abhishek Bansal, Medicine, Best Researcher Award

Doctorate Abhishek Bansal: Assistant professor at The oxford medical college hospital and research centre, India

Dr. Abhishek Bansal is a distinguished clinical biochemist with a deep focus on the biochemical underpinnings of diabetes, metabolic syndrome, kidney disorders, and molecular signaling. With an academic background including a Ph.D. in Medical Biochemistry from Malwanchal University, Indore, Dr. Bansal has established himself as a prominent researcher and educator. His work revolves around understanding chronic diseases and their biomarkers, contributing significantly to the advancement of clinical diagnostics. Dr. Bansal has authored 33 publications, including books, book chapters, and research articles, and has participated in numerous international workshops, enhancing his expertise in medical biochemistry and molecular diagnostics. He is currently an Assistant Professor at The Oxford Medical College, Hospital & Research Centre, Bangalore, where he continues to advance the field of biochemistry and mentor the next generation of researchers.

Online Profiles

Education

Dr. Abhishek Bansal’s educational journey is marked by rigorous academic training in medical biochemistry. He completed his Ph.D. in Medical Biochemistry at Malwanchal University, Indore in 2024, where his research focused on the evaluation of biomarkers for chronic kidney disease, a project supervised by Dr. Shreya Nigoskar. His M.Sc. in Medical Biochemistry was awarded by Jawaharlal Nehru Medical College, KAHER, Belagavi in 2020. His master’s thesis explored the correlation between plasma ascorbate levels and Type 2 diabetes management, supervised by Dr. Chetana P. Hadimani. Dr. Bansal’s foundational training began with a B.Sc. in Medical Laboratory Technology from MM(DU), Mullana, Haryana in 2016, where he was introduced to clinical laboratory technologies and methodologies. This combination of academic rigor and hands-on research experience has equipped him with a comprehensive understanding of medical biochemistry and clinical diagnostics.

Research Focus

Dr. Bansal’s research is deeply rooted in the intersection of clinical biochemistry, diabetes, metabolic syndrome, and kidney disorders. His research interests are specifically concentrated on identifying novel biomarkers that could improve the early detection, diagnosis, and management of chronic kidney disease (CKD) and metabolic diseases. He is particularly interested in molecular signaling pathways and their alterations in chronic diseases such as Type 2 diabetes and kidney dysfunction. Dr. Bansal’s recent work has led to an exploration of human neutrophil gelatinase-associated lipocalin (NGAL), asymmetric dimethylarginine (ADMA), and kidney injury molecule-1 (KIM-1) as promising biomarkers for CKD, which could significantly improve clinical outcomes through early intervention.

Experience

Dr. Bansal has accumulated diverse teaching and research experience in academic and clinical settings. He began his teaching career as a Tutor/Demonstrator in the Department of Biochemistry at Government Medical College, Rajouri (Aug 2021 – Apr 2022), where he helped students understand clinical biochemistry concepts and laboratory techniques. He later joined Pt. BDS PGIMS, Rohtak, where he continued in a similar role, further honing his teaching and research skills. Since June 2024, Dr. Bansal has been serving as Assistant Professor in the Department of Biochemistry at The Oxford Medical College, Hospital & Research Centre, Bangalore. In this position, he teaches undergraduate and postgraduate students, mentors research projects, and contributes to departmental initiatives in medical research.

Research Timeline

  • 2024: Ph.D. in Medical Biochemistry, Malwanchal University, Indore – Thesis on kidney disease biomarkers.

  • 2020: M.Sc. in Medical Biochemistry, Jawaharlal Nehru Medical College, KAHER, Belagavi – Research on plasma ascorbate levels in Type 2 diabetes.

  • 2016: B.Sc. in Medical Laboratory Technology, MM(DU), Mullana, Haryana – Gained foundational knowledge in clinical laboratory techniques.

  • Aug 2021 – Apr 2022: Tutor/Demonstrator, Govt. Medical College, Rajouri

  • Apr 2022 – May 2024: Tutor/Demonstrator, Pt. BDS PGIMS, Rohtak

  • Jun 2024 – Present: Assistant Professor, The Oxford Medical College, Hospital & Research Centre, Bangalore

  • 2018-2020: Conducted research on Vitamin C’s impact on Type 2 diabetes as part of M.Sc. thesis.

Awards & Honors

Dr. Bansal’s exceptional contributions to the field of medical biochemistry have earned him several prestigious fellowships and honors. He holds the title of FMIIP (Fellow, Medical and Industrial Institute of Pathology), FMERU (Fellow, Medical Education and Research University), and FMERC (Fellow, Medical and Educational Research Council), marking his academic excellence and contributions to clinical research. These recognitions are a testament to his sustained commitment to advancing medical education and clinical biochemistry.

Top-Noted Publication

Dr. Bansal’s research on chronic kidney disease biomarkers is widely regarded as one of his most impactful contributions. His doctoral thesis titled, “Evaluation of Serum Human Neutrophil Gelatinase-Associated Lipocalin, Asymmetric Dimethylarginine, Kidney Injury Molecule-1, and Beta-Trace Protein as Potential Biomarkers of Chronic Kidney Disease”, has been published in leading international journals. This work is a significant step forward in the identification of non-invasive biomarkers that can aid in the early diagnosis and prognosis of chronic kidney disease. His contributions to biochemistry and nephrology are shaping new approaches in clinical diagnostics.

1. Evaluating Asymmetric Dimethylarginine (ADMA) as a Biomarker for Preeclampsia: A Meta-Analysis

  • Journal: Journal of Neonatal Surgery

  • Year: 2025

  • DOI: 10.52783/jns.v14.1599

  • EID: 2-s2.0-85218718990

  • ISSN: 2226-0439

  • Contributors: Bansal, A.; Hadimani, C.P.; Patil, S.B.; Lah, N.A.Z.B.N.

  • Summary: This meta-analysis evaluates the potential of Asymmetric Dimethylarginine (ADMA) as a reliable biomarker for predicting preeclampsia, a condition that affects pregnant women and can lead to serious complications. This research contributes to improving early detection and management strategies for preeclampsia.

2. Serum Adipsin Levels as a New Marker in Type 2 Diabetes Mellitus: A Meta-Analysis

  • Journal: International Journal of Diabetes in Developing Countries

  • Year: 2025

  • DOI: 10.1007/s13410-025-01449-2

  • EID: 2-s2.0-85217198282

  • ISSN: 0973-3930, 1998-3832

  • Contributors: Bansal, A.; Honnapurmath, V.K.; Singh, A.

  • Summary: This meta-analysis investigates the relationship between serum adipsin levels and Type 2 diabetes mellitus (T2DM). The study highlights adipsin as a promising new biomarker for the disease, offering potential for improved diagnosis and therapeutic strategies in diabetic care.

3. Serum Fetuin-A as a Biomarker for Gestational Diabetes Mellitus: A Meta-Analysis

  • Journal: International Journal of Diabetes in Developing Countries

  • Year: 2025

  • DOI: 10.1007/s13410-025-01507-9

  • EID: 2-s2.0-105007297404

  • ISSN: 0973-3930, 1998-3832

  • Contributors: Bansal, A.; Pragaspathy, V.

  • Summary: This article explores the role of fetuin-A as a potential biomarker for gestational diabetes mellitus (GDM). By conducting a comprehensive meta-analysis, the study supports fetuin-A’s potential in predicting GDM, which could lead to better management and outcomes for pregnant women.

4. AEFI (Adverse Events Following Immunization) Among Children Less Than 2 Years Following Pentavalent Vaccine: A Cross-Sectional Study in India

  • Journal: Journal of Pharmaceutical and Therapeutic Research

  • Year: 2024

  • DOI: 10.53555/jptcp.v31i3.4779

  • Contributors: Dixit, P.; Prashant, P.; Gera, V.; Bansal, A.; Bansal, A.

  • Summary: This cross-sectional study investigates the adverse events following immunization (AEFI) in children under 2 years old in India after receiving the Pentavalent vaccine. The study provides valuable insights into vaccine safety and emphasizes the importance of monitoring adverse events post-vaccination.

5. Development of an Anti-Microbial Starch-Based Polymer Film Embedded with Silver Nanoparticles by Green Synthesis from Tea Extract: A Potential Low-Cost Wound Dressing for Rural Populations in Developing Countries

  • Journal: International Journal of Biomedical Nanoscience and Nanotechnology

  • Year: 2024

  • Report Type: Research Report

  • Contributors: Dinda, S.; Patil, A.B.; Hogade, S.A.; Bansal, A.

  • Summary: This innovative report outlines the development of a starch-based polymer film containing silver nanoparticles, synthesized through a green process using tea extract. The wound dressing, aimed at rural populations in developing countries, offers a low-cost, effective solution for wound care and antimicrobial protection.

Ferdi Gülaştı, Medicine, Best Innovator Award

Posted on by scizentox scizentoxLeave a Comment on Ferdi Gülaştı, Medicine, Best Innovator Award

Asst. Prof. Ferdi Gülaştı: Anesthesiologist at Adnan Menderes University, Turkey

Dr. Ferdi Gülaştı is a seasoned Anesthesiologist and Reanimation Specialist with extensive experience in clinical practice and cutting-edge research. A passionate advocate for advancing anesthesiology, he has made significant contributions to both the medical field and the scientific community. His expertise encompasses intraoperative management, advanced echocardiography, post-operative care, and the management of complex surgical patients. These qualities have cemented his position as a leading authority in his field.

Online Profiles

Scopus Profile
Dr. Gülaştı maintains a prominent online presence through academic and professional platforms. His Scopus profile reveals an impressive academic trajectory with 44 citations across 5 impactful publications. He is also active on ResearchGate and LinkedIn, where he shares valuable insights into his ongoing research and clinical work in anesthesiology.

Currently affiliated with Adnan Menderes University in Aydın, Turkey, Dr. Gülaştı’s research primarily focuses on anesthesia management, the cardiovascular impacts of anesthesia, and post-operative care. His recent works, such as the “The Effect of Upper Endoscopic Procedures Under Sedation on Ventricular Repolarization” published in Signa Vitae, reflect his dedication to exploring novel intersections between anesthesiology and cardiovascular health. His collaborative research with notable experts such as Sevil Gülaştı, Sercan Çayırlı, and Serra Topal showcases his team-oriented approach to advancing the field.

Education

Dr. Gülaştı completed his medical education at Istanbul University’s Faculty of Medicine, graduating in 2005. He pursued his specialization in Anesthesiology and Reanimation at Adnan Menderes University, where he trained extensively from 2012 to 2017. This robust academic foundation has enabled him to integrate clinical expertise with innovative research practices in anesthesiology.

Research Focus

Dr. Gülaştı’s research interests are rooted in understanding the physiological effects of anesthesia, particularly in high-risk surgeries. His pioneering work focuses on improving anesthesia techniques, exploring innovative pain management strategies, and utilizing advanced echocardiography to optimize patient outcomes. His expertise in ECMO (Extracorporeal Membrane Oxygenation) and intraoperative monitoring has further positioned him as a forward-thinking leader in anesthesiology.

Experience

With over a decade of clinical experience, Dr. Gülaştı has worked in several prestigious hospitals in Turkey, including his current role as a specialist at Aydın Kadın Doğum ve Çocuk Hastanesi. His previous positions at Bursa Şehir Hastanesi, Gediz Devlet Hastanesi, and Adnan Menderes University’s Anesthesiology Department have provided him with a wide range of clinical exposure, enhancing his skills in critical care and anesthesia management. His hands-on experience in managing complex patient cases has equipped him to implement innovative anesthetic techniques across diverse clinical settings.

Research Timeline

Dr. Gülaştı’s research journey has spanned several years, with his first major publication in 2015. His work, which spans topics such as anesthesia techniques, cardiovascular anesthesia, and post-operative management, has contributed significantly to the global body of anesthesiology knowledge. He continues to be a strong advocate for evidence-based practices, regularly contributing to national and international journals. His active role in global conferences underscores his commitment to sharing innovative findings with the wider medical community.

Awards & Honors

Dr. Gülaştı has received multiple accolades for his contributions to anesthesiology, reflecting his commitment to both advancing medical research and improving patient care. His innovation in the field has earned him recognition from prestigious academic institutions and medical organizations. These honors highlight his role as a leader and innovator in the field of anesthesiology.

Top-Noted Publication

One of Dr. Gülaştı’s most notable contributions is his chapter, “Mitral Kapak Onarımında İntraoperatif Transözefageal Ekokardiyografi ve Anestezi Yönetimi”, published in Vakalarla Kalp Damar Cerrahisi. His work is widely cited, particularly his studies on post-operative pain management and advanced anesthesiology techniques, which have been pivotal in advancing clinical practices globally.

“The Effect of Upper Endoscopic Procedures Under Sedation on Ventricular Repolarization: Retrospective Study”
Authors: Sevil Gülaştı, Ferdi Gülaştı, Sercan Çayırlı, Serra Topal, Direnc Yigit
Journal: Signa Vitae (2025, Open Access)
This retrospective study, soon to be published in Signa Vitae, investigates the effects of sedation on ventricular repolarization during upper endoscopic procedures, offering critical insights into the cardiovascular impact of anesthesia. This is a prime example of Dr. Gülaştı’s innovative research at the intersection of anesthesiology and cardiology.

Strengths for the Best Innovator Award

Dr. Gülaştı’s dedication to research, clinical excellence, and innovation in anesthesiology make him an ideal candidate for the Best Innovator Award. His pioneering work in intraoperative monitoring, sedation protocols, and cardiovascular anesthesia has not only shaped clinical practices but has also opened new avenues for improving patient safety and outcomes. His collaborative approach to research, coupled with his constant pursuit of evidence-based, cutting-edge solutions, showcases his ongoing commitment to pushing the boundaries of medical science.

1. Innovative Research Contributions

Dr. Gülaştı’s groundbreaking research in anesthesiology, particularly in the areas of cardiovascular anesthesia and intraoperative monitoring, underscores his innovative approach to improving patient outcomes. His work on advanced echocardiography in anesthesia management and studies like “The Effect of Upper Endoscopic Procedures Under Sedation on Ventricular Repolarization” exemplify his focus on integrating new methodologies and technologies into clinical practice. These contributions are not only scientifically valuable but also have practical implications for enhancing safety during complex surgeries.

2. Pioneering in Cardiovascular Anesthesia

Dr. Gülaştı has been at the forefront of exploring the cardiovascular effects of anesthesia. His research delves into the intricate balance of sedation and heart function, particularly in high-risk surgeries. By analyzing how anesthesia impacts ventricular repolarization and other cardiac functions, his work has opened new pathways for optimizing anesthetic protocols in patients with cardiovascular concerns. This pioneering work positions him as a leader in the intersection of anesthesiology and cardiology.

3. Advanced Techniques in Anesthesia Management

Dr. Gülaştı’s expertise in advanced anesthetic techniques, such as ECMO (Extracorporeal Membrane Oxygenation), and intraoperative monitoring, has revolutionized how complex surgeries are managed. By developing and applying advanced strategies for pain management and monitoring vital signs during surgery, he has significantly improved the quality of care for critically ill patients. His contributions to refining anesthesia protocols for high-risk procedures show his capacity to innovate in the most challenging clinical settings.

4. Collaborative and Interdisciplinary Approach

A hallmark of Dr. Gülaştı’s innovation is his collaborative spirit. He has worked alongside various experts in the fields of anesthesiology, cardiology, and surgery, creating a multidisciplinary approach to patient care. By partnering with colleagues like Sevil Gülaştı, Sercan Çayırlı, and Serra Topal, he has co-authored several influential studies, integrating diverse perspectives to find better solutions for complex clinical problems. This collaborative approach amplifies the impact of his research and clinical contributions.

5. Strong Commitment to Education and Mentorship

Dr. Gülaştı is not only a researcher and clinician but also an educator who mentors the next generation of anesthesiologists. His work at Adnan Menderes University, where he trains future specialists, highlights his role in shaping the future of anesthesiology. Through his teaching, he imparts innovative methodologies, emphasizing the importance of staying updated with new research and technologies. His dedication to education ensures that his innovative practices continue to influence the field for years to come.